<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>List of human proteins sharing homology with conserved regions of structural polyproteins of alphaviruses and shown to contribute to rheumatoid arthritis-like-condition.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Viral peptide</th>
    <th>Human peptide</th>
    <th>Human protein</th>
    <th>UniProt ID</th>
    <th>% similarity</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <underline>FIPT</underline>QTFY
    </td>
    <td>
     <underline>FIPT</underline>
    </td>
    <td>Ryanodine receptor 1</td>
    <td>P21817</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>KGRVVAIVLGGANEG
     <underline>ARTALS</underline>VVTW
    </td>
    <td>
     <underline>ARTALS</underline>
    </td>
    <td>Interleukin-17 receptor C</td>
    <td>Q8NAC3</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>TSAPCT
     <underline>ITGTM</underline>GHFILARCPKG
    </td>
    <td>
     <underline>ITGTM</underline>
    </td>
    <td>Monocyte differentiation antigen CD14</td>
    <td>P08571</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>
     <bold>RKGKIHIPF</bold>
     <bold>
      <underline>PLANVT</underline>
     </bold>
     <bold>CMVPKA</bold>
    </td>
    <td>
     <bold>
      <underline>PLANVT</underline>
     </bold>
    </td>
    <td>
     <bold>Alpha-1B-glycoprotein</bold>
     <sup>
      <xref ref-type="bibr" rid="CR44">44</xref>
     </sup>
    </td>
    <td>P04217</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>
     <underline>PTVTYG</underline>K
    </td>
    <td>
     <underline>PTVTYG</underline>
    </td>
    <td>Intercellular adhesion molecule 1</td>
    <td>P05362</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>
     <bold>P</bold>
     <bold>
      <underline>TVTY</underline>
     </bold>
     <bold>GK</bold>
    </td>
    <td>
     <bold>
      <underline>TVTY</underline>
     </bold>
    </td>
    <td>
     <bold>Low-density lipoprotein receptor-related protein 2</bold>
     <sup>
      <xref ref-type="bibr" rid="CR45">45</xref>
     </sup>
    </td>
    <td>P98164</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>CG
     <underline>TAEC</underline>
    </td>
    <td>
     <underline>TAEC</underline>
    </td>
    <td>Interleukin-23 receptor</td>
    <td>Q5VWK5</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>PDYSCKVFTGVYPFMWGGA
     <underline>YCFC</underline>D
    </td>
    <td>
     <underline>YCFC</underline>
    </td>
    <td>Platelet glycoprotein 4</td>
    <td>P16671</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>PDY
     <underline>SCKVF</underline>TGVYPFMWGGAYCFCD
    </td>
    <td>
     <underline>SCKVF</underline>
    </td>
    <td>Glucocorticoid receptor</td>
    <td>P04150</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>PDY
     <underline>SCKVF</underline>TGVYPFMWGGAYCFCD
    </td>
    <td>
     <underline>SCKVF</underline>
    </td>
    <td>Androgen receptor</td>
    <td>P10275</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>F
     <underline>STALA</underline>S
    </td>
    <td>
     <underline>STALA</underline>
    </td>
    <td>Leukocyte cell-derived chemotaxin-2</td>
    <td>O14960</td>
    <td>100%</td>
   </tr>
   <tr>
    <td>PPCIPCC
     <underline>YEKEPEE</underline>TLRMLEDNV
    </td>
    <td>
     <underline>YEKEP</underline>G
     <underline>EE</underline>
    </td>
    <td>Interleukin-1 receptor accessory protein</td>
    <td>Q9NPH3</td>
    <td>87.5%</td>
   </tr>
   <tr>
    <td>
     <bold>YSGGRFTIPTGA</bold>
     <bold>
      <underline>GKPGD</underline>
     </bold>
     <bold>S</bold>
     <bold>
      <underline>G</underline>
     </bold>
     <bold>RPIFDN</bold>
    </td>
    <td>
     <bold>
      <underline>GKPGD</underline>
     </bold>
     <bold>D</bold>
     <bold>
      <underline>G</underline>
     </bold>
    </td>
    <td>
     <bold>Collagen alpha-1(II) chain</bold>
     <sup>
      <xref ref-type="bibr" rid="CR46">46</xref>,
      <xref ref-type="bibr" rid="CR47">47</xref>
     </sup>
    </td>
    <td>P02458</td>
    <td>86%</td>
   </tr>
   <tr>
    <td>RKGKIHIPF
     <underline>PLANV</underline>T
     <underline>C</underline>MVPKA
    </td>
    <td>
     <underline>PLANV</underline>I
     <underline>C</underline>
    </td>
    <td>TNF receptor-associated factor 6</td>
    <td>Q9Y4K3</td>
    <td>85.7%</td>
   </tr>
   <tr>
    <td>
     <bold>YNMDYPPFGAGRPGQFGD</bold>
     <bold>
      <underline>I</underline>
     </bold>
     <bold>Q</bold>
     <bold>
      <underline>SRTPE</underline>
     </bold>
    </td>
    <td>
     <bold>
      <underline>I</underline>
     </bold>
     <bold>A</bold>
     <bold>
      <underline>SRTPE</underline>
     </bold>
    </td>
    <td>
     <bold>Annexin A5</bold>
     <sup>
      <xref ref-type="bibr" rid="CR48">48</xref>
     </sup>
    </td>
    <td>P08758</td>
    <td>85.7%</td>
   </tr>
   <tr>
    <td>DIP
     <underline>DAAFTR</underline>VVDAP
    </td>
    <td>
     <underline>DAAFTR</underline>I
    </td>
    <td>Vitronectin</td>
    <td>P04004</td>
    <td>85.7%</td>
   </tr>
   <tr>
    <td>P
     <underline>GYY</underline>Q
     <underline>LL</underline>
    </td>
    <td>
     <underline>GYY</underline>D
     <underline>LL</underline>
    </td>
    <td>Ryanodine receptor 1</td>
    <td>P21817</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>D
     <underline>GTLKI</underline>QVSLQIG
    </td>
    <td>N
     <underline>GTLKI</underline>
    </td>
    <td>T-cell surface antigen CD2</td>
    <td>P06729</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>T
     <underline>SAPCT</underline>ITGTMGHFILARCPKG
    </td>
    <td>
     <underline>SAPCT</underline>V
    </td>
    <td>Integrin alpha-IIb</td>
    <td>P08514</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>KWQYN
     <underline>SPLVP</underline>R
    </td>
    <td>D
     <underline>SPLVP</underline>
    </td>
    <td>Leptin receptor</td>
    <td>P48357</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>KWQYN
     <underline>SP</underline>L
     <underline>VPR</underline>
    </td>
    <td>
     <underline>SP</underline>I
     <underline>VPR</underline>
    </td>
    <td>Peptidoglycan recognition protein 1</td>
    <td>O75594</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>
     <bold>QAP</bold>
     <bold>
      <underline>SGF</underline>
     </bold>
     <bold>K</bold>
     <bold>
      <underline>YW</underline>
     </bold>
     <bold>LKE</bold>
    </td>
    <td>
     <bold>
      <underline>SGF</underline>
     </bold>
     <bold>I</bold>
     <bold>
      <underline>YW</underline>
     </bold>
    </td>
    <td>
     <bold>Low-density lipoprotein receptor-related protein 2</bold>
     <sup>
      <xref ref-type="bibr" rid="CR45">45</xref>
     </sup>
    </td>
    <td>P98164</td>
    <td>83.3%</td>
   </tr>
   <tr>
    <td>
     <underline>DGTL</underline>KI
     <underline>QV</underline>SLQIG
    </td>
    <td>
     <underline>DGTL</underline>F
     <underline>K</underline>V
     <underline>QV</underline>
    </td>
    <td>Beta-sarcoglycan</td>
    <td>Q16585</td>
    <td>77.8%</td>
   </tr>
   <tr>
    <td>M
     <underline>KS</underline>D
     <underline>A</underline>S
     <underline>KFT</underline>HEKPEGYYNWHHGAVQ
    </td>
    <td>
     <underline>KS</underline>E
     <underline>A</underline>D
     <underline>KFT</underline>
    </td>
    <td>Immunoglobulin superfamily member 6</td>
    <td>O95976</td>
    <td>75%</td>
   </tr>
   <tr>
    <td>YSGGRFTIPTG
     <underline>AG</underline>K
     <underline>PG</underline>D
     <underline>SG</underline>RPIFDN
    </td>
    <td>
     <underline>AG</underline>R
     <underline>PG</underline>N
     <underline>SG</underline>
    </td>
    <td>Macrophage scavenger receptor types I and II</td>
    <td>P21757</td>
    <td>75%</td>
   </tr>
   <tr>
    <td>KFIVGPMSSAWTP
     <underline>FDN</underline>KI
     <underline>VVY</underline>KGDV
    </td>
    <td>
     <underline>FDN</underline>TT
     <underline>VVY</underline>
    </td>
    <td>Interleukin-23 receptor</td>
    <td>Q5VWK5</td>
    <td>75%</td>
   </tr>
   <tr>
    <td>SKDVYAN
     <underline>T</underline>QLV
     <underline>LQRP</underline>AAGTVHVPYS
    </td>
    <td>
     <underline>T</underline>KLL
     <underline>LQRP</underline>
    </td>
    <td>High affinity immunoglobulin gamma Fc receptor I</td>
    <td>P12314</td>
    <td>75%</td>
   </tr>
   <tr>
    <td>APFGCQIATNPVRAMNC
     <underline>A</underline>V
     <underline>G</underline>N
     <underline>MPIS</underline>
    </td>
    <td>
     <underline>A</underline>L
     <underline>G</underline>Q
     <underline>MPIS</underline>
    </td>
    <td>Coagulation factor V</td>
    <td>P12259</td>
    <td>75%</td>
   </tr>
   <tr>
    <td>RKGKIHIPF
     <underline>P</underline>LA
     <underline>NVTC</underline>MVPKA
    </td>
    <td>
     <underline>P</underline>MV
     <underline>NVTC</underline>
    </td>
    <td>MHC class I polypeptide-related sequence B</td>
    <td>Q29980</td>
    <td>71.4%</td>
   </tr>
   <tr>
    <td>KFIVGPMSSA
     <underline>W</underline>T
     <underline>PF</underline>D
     <underline>NK</underline>IVVYKGDV
    </td>
    <td>
     <underline>W</underline>I
     <underline>PF</underline>Q
     <underline>NK</underline>
    </td>
    <td>Lymphocyte antigen 75</td>
    <td>O60449</td>
    <td>71.4%</td>
   </tr>
   <tr>
    <td>KPGRRERMCMKI
     <underline>EN</underline>D
     <underline>C</underline>I
     <underline>FE</underline>VK
    </td>
    <td>
     <underline>EN</underline>E
     <underline>C</underline>F
     <underline>FE</underline>
    </td>
    <td>Protocadherin-9</td>
    <td>Q9HC56</td>
    <td>71%</td>
   </tr>
   <tr>
    <td>
     <bold>SKDVYANTQLVL</bold>
     <bold>
      <underline>Q</underline>
     </bold>
     <bold>R</bold>
     <bold>
      <underline>PAAGTV</underline>
     </bold>
     <bold>H</bold>
     <bold>
      <underline>VP</underline>
     </bold>
     <bold>YS</bold>
    </td>
    <td>
     <bold>
      <underline>Q</underline>
     </bold>
     <bold>S</bold>
     <bold>
      <underline>PAAGTV</underline>
     </bold>
     <bold>QGR</bold>
     <bold>
      <underline>VP</underline>
     </bold>
    </td>
    <td>
     <bold>Cartilage intermediate layer protein 1</bold>
     <sup>
      <xref ref-type="bibr" rid="CR49">49</xref>,
      <xref ref-type="bibr" rid="CR50">50</xref>
     </sup>
    </td>
    <td>O75339</td>
    <td>69.2%</td>
   </tr>
   <tr>
    <td>FI
     <underline>PT</underline>QT
     <underline>FY</underline>
    </td>
    <td>
     <underline>PT</underline>EK
     <underline>FY</underline>
    </td>
    <td>Complement C3</td>
    <td>P01024</td>
    <td>67%</td>
   </tr>
   <tr>
    <td>
     <underline>CG</underline>T
     <underline>A</underline>E
     <underline>C</underline>
    </td>
    <td>
     <underline>CG</underline>V
     <underline>A</underline>Q
     <underline>C</underline>
    </td>
    <td>Integrin alpha-V</td>
    <td>P06756</td>
    <td>66.6%</td>
   </tr>
   <tr>
    <td>RKGKIH
     <underline>IP</underline>F
     <underline>PLA</underline>N
     <underline>VTC</underline>M
     <underline>V</underline>PKA
    </td>
    <td>
     <underline>IP</underline>I
     <underline>PLA</underline>-
     <underline>V</underline>IT
     <underline>TC</underline>I
     <underline>V</underline>
    </td>
    <td>Lymphocyte function-associated antigen 3</td>
    <td>P19256</td>
    <td>64. 3%</td>
   </tr>
   <tr>
    <td>NADLAKLAFKRSSK
     <underline>YDL</underline>E
     <underline>CA</underline>Q
     <underline>IP</underline>VH
    </td>
    <td>
     <underline>YDL</underline>D
     <underline>C</underline>PT
     <underline>A</underline>P
     <underline>IP</underline>
    </td>
    <td>TNF receptor-associated factor 6</td>
    <td>Q9Y4K3</td>
    <td>64%</td>
   </tr>
   <tr>
    <td>
     <underline>FI</underline>P
     <underline>TQTF</underline>Y
    </td>
    <td>
     <underline>FI</underline>S
     <underline>TQ</underline>QQV
     <underline>TF</underline>
    </td>
    <td>High affinity immunoglobulin epsilon receptor subunit alpha</td>
    <td>P12319</td>
    <td>60%</td>
   </tr>
   <tr>
    <td>P
     <underline>GYYQLL</underline>
    </td>
    <td>
     <underline>GY</underline>RETR
     <underline>YQLL</underline>
    </td>
    <td>N-alpha-acetyltransferase 16</td>
    <td>Q6N069</td>
    <td>60%</td>
   </tr>
   <tr>
    <td>
     <underline>PTVTYG</underline>K
    </td>
    <td>
     <underline>PTVT</underline>TGSG
     <underline>YG</underline>
    </td>
    <td>V-set and immunoglobulin domain-containing protein 4</td>
    <td>Q9Y279</td>
    <td>60%</td>
   </tr>
   <tr>
    <td>RKGKIH
     <underline>IP</underline>FP
     <underline>LA</underline>N
     <underline>VTC</underline>MV
     <underline>P</underline>KA
    </td>
    <td>
     <underline>IP</underline>Y-
     <underline>LA</underline>TD
     <underline>VTC</underline>VG
     <underline>P</underline>
    </td>
    <td>Toll-like receptor 7</td>
    <td>Q9NYK1</td>
    <td>57.1%</td>
   </tr>
   <tr>
    <td>
     <bold>E</bold>
     <bold>
      <underline>GL</underline>
     </bold>
     <bold>E</bold>
     <bold>
      <underline>V</underline>
     </bold>
     <bold>T</bold>
     <bold>
      <underline>W</underline>
     </bold>
     <bold>GNN</bold>
    </td>
    <td>
     <bold>D</bold>
     <bold>
      <underline>GL</underline>
     </bold>
     <bold>D</bold>
     <bold>
      <underline>V</underline>
     </bold>
     <bold>S</bold>
     <bold>
      <underline>W</underline>
     </bold>
    </td>
    <td>
     <bold>Chitinase-3-like protein 2</bold>
     <sup>
      <xref ref-type="bibr" rid="CR51">51</xref>
     </sup>
    </td>
    <td>Q15782</td>
    <td>57.1%</td>
   </tr>
   <tr>
    <td>
     <bold>F</bold>
     <bold>
      <underline>IP</underline>
     </bold>
     <bold>TQT</bold>
     <bold>
      <underline>FY</underline>
     </bold>
    </td>
    <td>
     <bold>
      <underline>IP</underline>
     </bold>
     <bold>SRS</bold>
     <bold>
      <underline>FY</underline>
     </bold>
    </td>
    <td>
     <bold>Cartilage intermediate layer protein 1</bold>
     <sup>
      <xref ref-type="bibr" rid="CR49">49</xref>,
      <xref ref-type="bibr" rid="CR50">50</xref>
     </sup>
    </td>
    <td>O75339</td>
    <td>57%</td>
   </tr>
   <tr>
    <td>
     <bold>MKSD</bold>
     <bold>
      <underline>A</underline>
     </bold>
     <bold>S</bold>
     <bold>
      <underline>KFT</underline>
     </bold>
     <bold>HEK</bold>
     <bold>
      <underline>P</underline>
     </bold>
     <bold>EG</bold>
     <bold>
      <underline>YY</underline>
     </bold>
     <bold>NWHHGAVQ</bold>
    </td>
    <td>
     <bold>
      <underline>A</underline>
     </bold>
     <bold>N</bold>
     <bold>
      <underline>KFT</underline>
     </bold>
     <bold>ETNPQV</bold>
     <bold>
      <underline>YY</underline>
     </bold>
    </td>
    <td>
     <bold>Low-density lipoprotein receptor-related protein 2</bold>
     <sup>
      <xref ref-type="bibr" rid="CR45">45</xref>
     </sup>
    </td>
    <td>P98164</td>
    <td>54%</td>
   </tr>
   <tr>
    <td>AYEHVTVI
     <underline>P</underline>N
     <underline>TVGVP</underline>YKTLVN
     <underline>R</underline>P
     <underline>GY</underline>
    </td>
    <td>
     <underline>P</underline>A
     <underline>TVGV</underline>TQ
     <underline>PY</underline>–LD
     <underline>R</underline>L
     <underline>GY</underline>
    </td>
    <td>Cartilage intermediate layer protein 2</td>
    <td>Q8IUL8</td>
    <td>52.6%</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Human proteins highlighted in bold are experimentally proven to have antibodies developed against them in patients diagnosed with rheumatoid arthritis.</p>
 </table-wrap-foot>
</table-wrap>
